[144] Atlanta Braves Holdings, Inc. Series C SEC Filing

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. (BATRK) filed a Form 144 notifying the proposed sale of 60,000 Series C common shares through UBS Financial Services on 08/21/2025 with an aggregate market value of $2,613,000. The shares were acquired the same day via a stock option exercise from Atlanta Braves Holdings, Inc., and payment was recorded on 08/21/2025. There were no securities sold by this person in the past three months. The filing represents a routine insider disposition reported under Rule 144 to comply with securities-sale reporting requirements.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 sale: compliant disclosure of insider exercise and proposed disposition, no recent prior sales reported.

The filing documents a standard post-exercise sale notice where 60,000 Series C shares are to be sold on NASDAQ via UBS Financial Services. The transaction was both acquired and paid for on 08/21/2025 through a stock option exercise, and the filer reports no sales in the prior three months. From a compliance perspective, the notice provides the necessary broker, class, amount, aggregate value, and timing details required for Rule 144 reporting. There is no indication here of unusual trading patterns or clustered prior disposals.

Equity Analyst

TL;DR: Disposal size is immaterial relative to outstanding shares; this is unlikely to affect market dynamics.

Sixty thousand shares represent a small fraction of the reported outstanding Series C share count of 51,459,265. The aggregate value of $2,613,000 signals a modest insider sale following an option exercise rather than a disposal of a large holding. There are no disclosures here of additional context such as planned further sales, trading plans, or material non-public information. For investors, this appears operationally routine and not a material event for company valuation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Series C Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	60000	2613000	51459265	08/21/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series C Common Stock	08/21/2025	Stock Option Exercise	Atlanta Braves Holdings, Inc.			60000	08/21/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What transaction is reported in the BATRK Form 144?

The Form 144 reports the proposed sale of 60,000 Series C common shares to be sold on 08/21/2025 through UBS Financial Services on NASDAQ.

How were the shares acquired according to the filing?

The shares were acquired on 08/21/2025 via a stock option exercise from Atlanta Braves Holdings, Inc., with payment recorded the same day.

What is the aggregate market value of the shares to be sold?

The aggregate market value reported is $2,613,000 for the 60,000 Series C shares.

How many Series C shares are outstanding per the filing?

The filing lists 51,459,265 Series C shares outstanding.

Did the filer sell any securities in the past three months?

No. The filing states Nothing to Report under securities sold during the past three months.